Cargando…
Diagnostic Value of the Care™ HPV Test in Screening for Cervical Intraepithelial Neoplasia Grade 2 or Worse
BACKGROUND: Cervical cancer is the fourth leading cause of cancer death in women worldwide. Persistent infection with a high risk human papillomavirus (HR-HPV) is the main etiological factor, so that early early detection of HR-HPV is very important. The aim of this study was to investigate the effi...
Autores principales: | Zarchi, Mojgan Karimi, Heydari, Effat, Tabatabaie, Afsarolsadat, Moghimi, Mansour, Kooti, Wesam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464485/ https://www.ncbi.nlm.nih.gov/pubmed/28440976 http://dx.doi.org/10.22034/APJCP.2017.18.3.687 |
Ejemplares similares
-
Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged ≥ 69 referred to colposcopy due to an HPV-positive screening test
por: Booth, Berit B., et al.
Publicado: (2023) -
HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia
por: Bierkens, Mariska, et al.
Publicado: (2012) -
Persistent HPV-16 infection leads to recurrence of high-grade cervical intraepithelial neoplasia
por: Byun, Jung Mi, et al.
Publicado: (2018) -
Genotype-specific methylation of HPV in cervical intraepithelial neoplasia
por: Hsu, Yaw-Wen, et al.
Publicado: (2017) -
HPV 16 Is Related to the Progression of Cervical Intraepithelial Neoplasia Grade 2: A Case Series
por: Loffredo D'Ottaviano, Maria Gabriela, et al.
Publicado: (2013)